Budget Amount *help |
¥2,860,000 (Direct Cost: ¥2,200,000、Indirect Cost: ¥660,000)
Fiscal Year 2020: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2019: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
|
Outline of Final Research Achievements |
Gut microbial dysbiosis affects the occurrence of gastrointestinal diseases, such as inflammatory bowel diseases, and systemic autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis. Here, we performed metagenomic analysis of breast cancer patients as a non-gastrointestinal tract cancer, which affects carcinogenesis, cancer promotion, tumor microenvironment, and host cancer immunological response, especially as compared with colon cancer patients, using the TCGA and BIC databases. As a result, the microbial flora in breast cancer patients differs from that in colon cancer patients. The high relative abundance of the Genus Bifidobacterium, which is thought to enhance T-cell response, and low relative abundance of Genus Prevotella, are correlated with better prognosis in breast cancer patients.
|